Last updated: about 1 month ago
AstraZeneca's $2.5B Investment: Boosting R&D and Biotech in Beijing
AstraZeneca PLC commits $2.5 billion to establish a global R&D center in Beijing, enhancing local biotech partnerships and expanding its workforce to 1,700 to advance life sciences.